Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2025 Jun;12(6):1144-1150.
doi: 10.1002/acn3.70048. Epub 2025 Apr 14.

Long-Term Survival, Burden of Disease, and Patient-Centered Outcomes in Maximally Treated Intracerebral Hemorrhage

Affiliations
Observational Study

Long-Term Survival, Burden of Disease, and Patient-Centered Outcomes in Maximally Treated Intracerebral Hemorrhage

Anne Mrochen et al. Ann Clin Transl Neurol. 2025 Jun.

Abstract

Objective: Increasing evidence shows that patients with intracerebral hemorrhage (ICH) can achieve better-than-expected outcomes with aggressive therapy. However, real-world long-term data, patient-centered outcomes, and societal measures after maximal ICH treatment are lacking. This study aimed to analyze 5-year survival, utility-weighted functional outcomes, and burden of disease in maximally treated ICH patients, stratified by max-ICH Score.

Methods: This study investigated consecutive patients with spontaneous ICH included in the single-center Longitudinal Cohort Study on ICH Care (UKER-ICH, NCT03183167, 2006-2015). We included all patients without early care limitations, hereinafter referred to as maximally treated. We analyzed the stratification by max-ICH Score of cumulative 5-year survival using Kaplan-Meier estimates and COX regression modeling, disease burden using disability-adjusted life years (DALYs), and patient-centered outcome at 12 months using the Utility-Weighted modified Rankin Scale (UW-mRS).

Results: The 5-year survival rate of the included 1022 maximally treated patients was 53%, stratified by max-ICH Score (0 points: 85%, 1: 91%, 2: 69%, 3: 59%, 4: 47%, 5: 32%, 6: 29%, 7: 18%, ≥ 8: 0%, log-rank p < 0.001). The mean number of DALYs was 8.94 (±8.15, standard deviation [SD]), consisting of 4.27 years of life lost (±7.79, SD) and 4.67 years lived with disability (±6.38, SD). Patients with a max-ICH Score of 5 had the highest burden of disease (12.76 [±9.43, SD]). The mean UW-mRS at 12 months was 0.45 (±0.37, SD) and decreased with increasing max-ICH Score (0: 0.80 [±0.23], 1: 0.73 [±0.29], 2: 0.67 [±0.29], 3: 0.50 [±0.34], 4: 0.39 [±0.34], 5: 0.25 [±0.30], 6: 0.19 [±0.28], 7: 0.16 [±0.26], ≥ 8: 0.08 [±0.22], p < 0.001).

Interpretation: These observational data, stratified by max-ICH Score, provide patients and treating physicians with an initial severity assessment in terms of potential long-term patient-centered outcomes and burden of disease following maximal treatment.

Keywords: intracerebral hemorrhage prognosis; patient‐centered outcomes; stroke disability burden.

PubMed Disclaimer

Conflict of interest statement

M.I.S. reported receiving grants from the Interdisziplinäres Zentrum für Klinische Forschung, Marohn Foundation, Doktor Robert Pfleger‐Stiftung, and German Society for Neurointensive Care and Emergency Medicine (DGNI) for work outside the submitted work.

A.M. reports personal fees from Alexion Pharma Germany GmbH and Roche Pharma GmbH, outside the submitted work. J.A.S. reports personal fees from Lilly Deutschland GmbH, outside the submitted work.

Figures

FIGURE 1
FIGURE 1
Kaplan–Meier survival curves after maximal treatment stratified by the max‐ICH Score. Kaplan–Meier survival curves illustrate the survival probabilities over a 5‐year period. The curves are segmented according to max‐ICH Scores, highlighting differences in survival outcomes based on the severity of the initial ICH. The “Number at Risk Table” provides the count of patients at the beginning of each annual interval for each max‐ICH Score group.
FIGURE 2
FIGURE 2
Hazard of mortality after maximal treatment stratified by the max‐ICH Score. Cox proportional hazards regression analysis was conducted to assess the relative hazard of death, with 95% confidence intervals (CI), associated with each max‐ICH Score. The reference group for this analysis was the group with a max‐ICH Score of 0. The results illustrate the relationship between increasing max‐ICH Scores and the hazard of death. Abbreviations: CI, confidence interval; ICH, intracerebral hemorrhage.
FIGURE 3
FIGURE 3
The burden of disease after maximal treatment stratified by the max‐ICH Score. The number and subdivision of disability‐adjusted life years (DALYs) were analyzed for each max‐ICH Score. The red bar represents the total DALYs, which are composed of years lived with disability (YLD, light gray bar) and years of life lost (YLL, dark gray bar). To assist in the interpretation of the combined analysis of morbidity and mortality, the average age (in years) of the patients with individual max‐ICH Scores is also provided.
FIGURE 4
FIGURE 4
Patient‐centered functional long‐term outcome after maximal treatment stratified by the max‐ICH Score. The patient‐centered functional outcome 12 months after maximal treatment was analyzed using the utility‐weighted mRS. Results are presented separately for each max‐ICH Score, indicating the mean UW‐mRS and standard deviation (SD). Abbreviations: ICH, intracerebral hemorrhage; mRS, modified Rankin Scale.

Similar articles

References

    1. Greenberg S. M., Ziai W. C., Cordonnier C., et al., “2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage: A Guideline From the American Heart Association/American Stroke Association,” Stroke 53, no. 7 (2022): e282–e361. - PubMed
    1. Zahuranec D. B., Brown D. L., Lisabeth L. D., et al., “Early Care Limitations Independently Predict Mortality After Intracerebral Hemorrhage,” Neurology 68, no. 20 (2007): 1651–1657. - PubMed
    1. Becker K. J., Baxter A. B., Cohen W. A., et al., “Withdrawal of Support in Intracerebral Hemorrhage May Lead to Self‐Fulfilling Prophecies,” Neurology 56, no. 6 (2001): 766–772. - PubMed
    1. Morgenstern L. B., Zahuranec D. B., Sanchez B. N., et al., “Full Medical Support for Intracerebral Hemorrhage,” Neurology 84, no. 17 (2015): 1739–1744. - PMC - PubMed
    1. Shah V. A., Thompson R. E., Yenokyan G., et al., “One‐Year Outcome Trajectories and Factors Associated With Functional Recovery Among Survivors of Intracerebral and Intraventricular Hemorrhage With Initial Severe Disability,” JAMA Neurology 79, no. 9 (2022): 856–868. - PMC - PubMed

Publication types

LinkOut - more resources